Intrinsic Value of S&P & Nasdaq Contact Us

Lipella Pharmaceuticals Inc. LIPO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
+6566.7%

Lipella Pharmaceuticals Inc. (LIPO) has 9 known insider and institutional holders on record. The largest holder is Chancellor Michael B with 80,000 shares. Other notable holders include Johnston Douglas and Pruchnic Ryan.

LIPO Insider Ownership

Top Holder
Chancellor Michael B
80,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Chancellor Michael B 10 Percent Owner, Officer: Chief Medical Officer 80,000 2024-03-19
100%
2 Johnston Douglas Chief Financial Officer 50,000 2024-03-19
63%
3 Pruchnic Ryan Director 25,000 2024-03-19
31%
4 Birder Lori Director 25,000 2024-03-19
31%
5 Kim Byong Director 25,000 2024-03-19
31%
6 Cohen Daniel R Director 25,000 2024-03-19
31%
7 Battleman David S. Director 25,000 2023-06-21
31%
8 Yoshimura Naoki Director 25,000 2024-03-19
31%
9 Kaufman Jonathan H 10 Percent Owner, Officer: See Remarks Below. 4,060 2025-03-17
5%

No ownership data available for LIPO.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message